Elizabeth R Smith - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elizabeth R Smith

Showing results (71-80 of 74) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 74 results.

JAMA Pediatrics|May 22, 2023

Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.

Pharmacoepidemiology and Drug Safety|May 6, 2025

Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.

Vaccine|October 4, 2022

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.

JAMA Network Open|April 24, 2024

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.

Pageof 8

Search research articles

Showing results (71-80 of 74) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 74 results.

JAMA Pediatrics|May 22, 2023

Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.

Pharmacoepidemiology and Drug Safety|May 6, 2025

Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.

Vaccine|October 4, 2022

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.

JAMA Network Open|April 24, 2024

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.

Pageof 8